2P3G

Crystal structure of a pyrrolopyridine inhibitor bound to MAPKAP Kinase-2


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.8 Å
  • R-Value Free: 0.374 
  • R-Value Work: 0.300 

wwPDB Validation 3D Report Full Report


This is version 1.3 of the entry. See complete history

Literature

Pyrrolopyridine Inhibitors of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK-2).

Anderson, D.R.Meyers, M.J.Vernier, W.F.Mahoney, M.W.Kurumbail, R.G.Caspers, N.Poda, G.I.Schindler, J.F.Reitz, D.B.Mourey, R.J.

(2007) J.Med.Chem. 50: 2647-2654

  • DOI: 10.1021/jm0611004

  • PubMed Abstract: 
  • A new class of potent kinase inhibitors selective for mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2 or MK-2) for the treatment of rheumatoid arthritis has been prepared and evaluated. These inhibitors have IC50 values as low ...

    A new class of potent kinase inhibitors selective for mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2 or MK-2) for the treatment of rheumatoid arthritis has been prepared and evaluated. These inhibitors have IC50 values as low as 10 nM against the target and have good selectivity profiles against a number of kinases including CDK2, ERK, JNK, and p38. These MK-2 inhibitors have been shown to suppress TNFalpha production in U397 cells and to be efficacious in an acute inflammation model. The structure-activity relationships of this series, the selectivity for MK-2 and their activity in both in vitro and in vivo models are discussed. The observed selectivity is discussed with the aid of an MK-2/inhibitor crystal structure.


    Organizational Affiliation

    Pfizer Global Research and Development, St. Louis Laboratories, 700 Chesterfield Parkway W, Chesterfield, Missouri 63017, USA. david.r.anderson@pfizer.com




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
MAP kinase-activated protein kinase 2
X
327Homo sapiensMutation(s): 0 
Gene Names: MAPKAPK2
EC: 2.7.11.1
Find proteins for P49137 (Homo sapiens)
Go to Gene View: MAPKAPK2
Go to UniProtKB:  P49137
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
F10
Query on F10

Download SDF File 
Download CCD File 
X
2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE
C18 H14 F N3 O
XJJYJNMNYDNXNO-UHFFFAOYSA-N
 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
F10IC50: 126 - 8900 nM (100) BINDINGDB
F10EC50: 372 - 2700 nM (100) BINDINGDB
F10IC50: 126 nM PDBBIND
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.8 Å
  • R-Value Free: 0.374 
  • R-Value Work: 0.300 
  • Space Group: F 41 3 2
Unit Cell:
Length (Å)Angle (°)
a = 253.941α = 90.00
b = 253.941β = 90.00
c = 253.941γ = 90.00
Software Package:
Software NamePurpose
PDB_EXTRACTdata extraction
X-PLORphasing
DENZOdata reduction
ADSCdata collection
SCALEPACKdata scaling
HKL-2000data reduction
REFMACrefinement

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

Revision History 

  • Version 1.0: 2007-06-12
    Type: Initial release
  • Version 1.1: 2008-03-05
    Type: Version format compliance
  • Version 1.2: 2011-07-13
    Type: Version format compliance
  • Version 1.3: 2017-10-18
    Type: Refinement description